| 靶点: |
IC50: 90 nM (human BRD4 BD1) |
| 体内研究: |
ZL0590 (Compound 52) (10 mg/kg,口服,在 poly(I:C) 前 1 天) 完全抑制了聚 (I:C) 诱导的 C57BL/6J 小鼠中小型气道周围的中性粒细胞炎症。 |
| 参考文献: |
1. Liu Z, et al. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. J Med Chem. 2022;65(3):2388-2408. 2. Yi Li, et al., DEVELOPMENT OF SMALL MOLECULE EPIGENETIC THERAPEUTICS FOR INFLAMMATORY BOWEL DISEASE, 2021 160(3). |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.951 ml |
9.755 ml |
19.51 ml |
| 5 mM |
0.39 ml |
1.951 ml |
3.902 ml |
| 10 mM |
0.195 ml |
0.976 ml |
1.951 ml |
| 50 mM |
0.039 ml |
0.195 ml |
0.39 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |